Literature DB >> 29604205

Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms.

Hyesook Yoon1,2,3, Maja Radulovic1,2, Isobel A Scarisbrick1,2,3.   

Abstract

Kallikrein-related peptidase 6 (Klk6) is the most abundant serine proteinase in the adult central nervous system (CNS), yet we know little regarding its physiological roles or mechanisms of action. Levels of Klk6 in the extracellular environment are dynamically regulated in CNS injury and disease positioning this secreted enzyme to affect cell behavior by potential receptor dependent and independent mechanisms. Here we show that recombinant Klk6 evokes increases in intracellular Ca2+ in primary astrocyte monolayer cultures through activation of proteinase activated receptor 1 (PAR1). In addition, Klk6 promoted a condensation of astrocyte cortical actin leading to an elongated stellate shape and multicellular aggregation in a manner that was dependent on the presence of either PAR1 or PAR2. Klk6-evoked changes in astrocyte shape were accompanied by translocation of β-catenin from the plasma membrane to the cytoplasm. These data are exciting because they demonstrate that Klk6 can influence astrocyte plasticity through receptor-dependent mechanisms. Furthermore, this study expands our understanding of the mechanisms by which kallikreins can contribute to neural homeostasis and remodeling and point to both PAR1 and PAR2 as new therapeutic targets to modulate astrocyte form and function.

Entities:  

Keywords:  astrogliosis; calcium signaling; kallikrein; neurosin; β-catenin

Mesh:

Substances:

Year:  2018        PMID: 29604205      PMCID: PMC6092205          DOI: 10.1515/hsz-2018-0122

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  77 in total

1.  Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.

Authors:  K Ogawa; T Yamada; Y Tsujioka; J Taguchi; M Takahashi; Y Tsuboi; Y Fujino; M Nakajima; T Yamamoto; H Akatsu; S Mitsui; N Yamaguchi
Journal:  Psychiatry Clin Neurosci       Date:  2000-08       Impact factor: 5.188

2.  Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain.

Authors:  S P Little; E P Dixon; F Norris; W Buckley; G W Becker; M Johnson; J R Dobbins; T Wyrick; J R Miller; W MacKellar; D Hepburn; J Corvalan; D McClure; X Liu; D Stephenson; J Clemens; E M Johnstone
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

3.  Genetically encoded calcium indicators and astrocyte calcium microdomains.

Authors:  Xiaoping Tong; Eiji Shigetomi; Loren L Looger; Baljit S Khakh
Journal:  Neuroscientist       Date:  2012-12-20       Impact factor: 7.519

4.  Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).

Authors:  Katerina Oikonomopoulou; Kristina K Hansen; Mahmoud Saifeddine; Nathalie Vergnolle; Illa Tea; Michael Blaber; Sachiko I Blaber; Isobel Scarisbrick; Eleftherios P Diamandis; Morley D Hollenberg
Journal:  Biol Chem       Date:  2006-06       Impact factor: 3.915

5.  Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia.

Authors:  Emma L Ashby; Patrick G Kehoe; Seth Love
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

6.  Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis.

Authors:  Leonie A Boven; Nathalie Vergnolle; Scot D Henry; Claudia Silva; Yoshinori Imai; Janet Holden; Kenneth Warren; Morley D Hollenberg; Christopher Power
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

7.  Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord.

Authors:  Ryuji Terayama; Yoshio Bando; Takayuki Takahashi; Shigetaka Yoshida
Journal:  Glia       Date:  2004-11-01       Impact factor: 7.452

8.  Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.

Authors:  Hyesook Yoon; Maja Radulovic; Jianmin Wu; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2013-05-27       Impact factor: 5.372

9.  The protease-activated receptor-3 (PAR-3) can signal autonomously to induce interleukin-8 release.

Authors:  E Ostrowska; G Reiser
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

10.  KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species.

Authors:  Georgios Pampalakis; Vasia-Samantha Sykioti; Methodios Ximerakis; Ioanna Stefanakou-Kalakou; Ronald Melki; Kostas Vekrellis; Georgia Sotiropoulou
Journal:  Oncotarget       Date:  2017-02-28
View more
  3 in total

1.  Blocking the Thrombin Receptor Promotes Repair of Demyelinated Lesions in the Adult Brain.

Authors:  Hyesook Yoon; Chan-Il Choi; Erin M Triplet; Monica R Langley; Laurel S Kleppe; Ha Neui Kim; Whitney L Simon; Isobel A Scarisbrick
Journal:  J Neurosci       Date:  2020-01-07       Impact factor: 6.167

2.  Blocking Kallikrein 6 promotes developmental myelination.

Authors:  Hyesook Yoon; Erin M Triplet; Whitney L Simon; Chan-Il Choi; Laurel S Kleppe; Elena De Vita; Aubry K Miller; Isobel A Scarisbrick
Journal:  Glia       Date:  2021-10-09       Impact factor: 7.452

3.  The thrombin receptor modulates astroglia-neuron trophic coupling and neural repair after spinal cord injury.

Authors:  Ha Neui Kim; Erin M Triplet; Maja Radulovic; Samantha Bouchal; Laurel S Kleppe; Whitney L Simon; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2021-04-22       Impact factor: 8.073

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.